We are live on
!
Find out more
FCM
Frontier Capital Management Portfolio holdings
AUM
$9.73B
1-Year Est. Return
55.65%
This Fund
S&P 500
This Quarter
Est. Return
+7.93%
1 Year Est. Return
+55.65%
3 Year Est. Return
+154.46%
5 Year Est. Return
+213.15%
10 Year Est. Return
+1,202.39%
AUM
$15.5B
AUM Growth
+$1.41B
(+10%)
Cap. Flow
+$580M
Cap. Flow
% of AUM
3.73%
Top 10 Holdings %
Top 10 Hldgs %
13.97%
Holding
316
New
18
Increased
157
Reduced
112
Closed
29
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Caesars Entertainment
CZR
|
+$88.1M |
| 2 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$73.8M |
| 3 |
Ulta Beauty
ULTA
|
+$72.3M |
| 4 |
Workday
WDAY
|
+$59.6M |
| 5 |
Nutanix
NTNX
|
+$55.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IDTI
Integrated Device Technology I
IDTI
|
+$144M |
| 2 |
Zoetis
ZTS
|
+$140M |
| 3 |
Hexcel
HXL
|
+$74.3M |
| 4 |
Eagle Materials
EXP
|
+$69.9M |
| 5 |
AHL
ASPEN Insurance Holding Limited
AHL
|
+$67.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.31% |
| 2 | Industrials | 17.5% |
| 3 | Healthcare | 14.9% |
| 4 | Consumer Discretionary | 12.33% |
| 5 | Financials | 12.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
PRA Group
PRAA
$672M
| $14.7M | 0.09% |
408,433
+39,944
| +11% | +$1.56M |
|
|
MODN
227
DELISTED
MODEL N, INC.
MODN
| $14M | 0.09% |
882,446
+800,492
| +977% | +$14M |
|
|
RP
228
DELISTED
RealPage, Inc.
RP
| $13.9M | 0.09% |
211,030
-134,254
| -39% | -$8.01M |
|
|
CY
229
DELISTED
Cypress Semiconductor
CY
| $13.4M | 0.09% |
923,032
-451,379
| -33% | -$7.43M |
|
|
NE
230
DELISTED
Noble Corporation
NE
| $13.2M | 0.09% |
1,880,583
+1,279,673
| +213% | +$7.76M |
|
231
Appian
APPN
$2.11B
| $13.2M | 0.09% |
398,839
+113,780
| +40% | +$3.88M |
|
232
Gogo Inc
GOGO
$525M
| $13.2M | 0.08% |
2,534,055
-54,511
| -2% | -$242K |
|
|
MIME
233
DELISTED
Mimecast Limited
MIME
| $13.1M | 0.08% |
311,681
+12,921
| +4% | +$525K |
|
|
ZUO
234
DELISTED
Zuora, Inc.
ZUO
| $12.7M | 0.08% |
550,663
+427,730
| +348% | +$11.4M |
|
|
INST
235
DELISTED
Instructure, Inc.
INST
| $12.1M | 0.08% |
340,918
-61,603
| -15% | -$2.53M |
|
|
RPT
236
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $11.5M | 0.07% |
+847,534
| New | +$11.3M |
|
237
Veeco
VECO
$2.62B
| $11.4M | 0.07% |
1,112,083
-1,100,404
| -50% | -$13.8M |
|
|
IBKC
238
DELISTED
IBERIABANK Corp
IBKC
| $11.3M | 0.07% |
138,474
+40,276
| +41% | +$3.35M |
|
|
BLUE
239
DELISTED
bluebird bio
BLUE
| $10.1M | 0.06% |
5,328
-1,994
| -27% | -$4.12M |
|
240
Cushman & Wakefield Ltd
CWK
$3.16B
| $9.86M | 0.06% |
+580,407
| New | +$10.4M |
|
|
MASI
241
DELISTED
Masimo
MASI
| $9.62M | 0.06% |
77,231
-61,199
| -44% | -$6.79M |
|
|
ADAP
242
DELISTED
Adaptimmune Therapeutics
ADAP
| $9.47M | 0.06% |
698,694
+543,809
| +351% | +$5.7M |
|
|
WBC
243
DELISTED
WABCO HOLDINGS INC.
WBC
| $9.16M | 0.06% |
77,712
-2,751
| -3% | -$332K |
|
244
Caesarstone
CSTE
$69.5M
| $8.87M | 0.06% |
478,319
-61,043
| -11% | -$1.07M |
|
|
LOXO
245
DELISTED
Loxo Oncology, Inc
LOXO
| $8.8M | 0.06% |
51,542
+24,891
| +93% | +$4.18M |
|
246
Darling Ingredients
DAR
$9.32B
| $8.8M | 0.06% |
455,344
+68,548
| +18% | +$1.35M |
|
|
SGEN
247
DELISTED
Seagen Inc. Common Stock
SGEN
| $8.62M | 0.06% |
111,795
+52,532
| +89% | +$3.87M |
|
248
Golar LNG
GLNG
$4.82B
| $8.46M | 0.05% |
304,231
-9,269
| -3% | -$246K |
|
|
INVX
249
Innovex International
INVX
$1.8B
| $7.95M | 0.05% |
152,196
-5,330
| -3% | -$278K |
|
|
MDSO
250
DELISTED
Medidata Solutions, Inc.
MDSO
| $7.81M | 0.05% |
106,515
-127,288
| -54% | -$10.2M |
|
Similar funds
HL
DCP
CCM
URS
CIM
MPI
TIM
DPIM
Frontier Capital Management's Q3 2018 Portfolio in Review
As of Q3 2018, Frontier Capital Management held 316 positions worth $15.5B, up 10% from $14.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Frontier Capital Management deployed $580M of net new capital in Q3 2018, opening 18 new positions and adding to 157 existing holdings. Its largest new stake was PRA Health Sciences, Inc.: 709,009 shares worth $78.1M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was Integrated Device Technology I, an estimated $144M trimmed.
- Frontier Capital Management's largest Q3 2018 buy was PRA Health Sciences, Inc.: 709,009 shares worth $78.1M.
- Frontier Capital Management added most to Caesars Entertainment in Q3 2018, an estimated $88.1M increase.
- Frontier Capital Management's biggest Q3 2018 reduction was Integrated Device Technology I, cutting an estimated $144M.
- Frontier Capital Management fully exited Hexcel in Q3 2018, selling an estimated $74.3M.
- Frontier Capital Management's ten largest holdings make up 14% of its $15.5B portfolio in Q3 2018.
- Frontier Capital Management opened 18 new positions and closed 29 in Q3 2018.
- Frontier Capital Management's portfolio value rose 10% quarter-over-quarter to $15.5B.
Based on Frontier Capital Management's 13F filing for Q3 2018, filed 30 Oct 2018.